Image For Activity Cover
Impact of Bleeding Risk and Inflammation on Cardiovascular Outcomes After Percutaneous Coronary Intervention (JACC Cardiovascular Interventions February 2024)

Markers of systemic inflammation, such as high-sensitivity C-reactive protein (hsCRP), have been associated with the occurrence of major adverse cardiovascular and cerebrovascular events (MACCE) in patients undergoing percutaneous coronary intervention (PCI). Whether this risk varies according to the presence of high bleeding risk (HBR) conditions is unclear.


JACC: Cardiovascular Interventions Editor-in-Chief
David J. Moliterno, MD, FACC

JACC: Cardiovascular Interventions CME/MOC Editor
Michael C. McDaniel, MD

Manish Vinayak, MD
Davide Cao, MD
Roxana Mehran, MD

Important Dates

Date of Release: February 12, 2024
Term of Approval/Date of CME/MOC Expiration: February 11, 2025

Availability: On-Demand
Expires on Feb 11, 2025
Cost: FREE
Credit Offered:
1 CME Credit
1 ABIM-MOC Point
Android App Download IOS App Download Powered By